查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1401929

2030 年藥物醫囑遵從性市場預測：按類型、藥物和地區分類的全球分析

Medication Adherence Market Forecasts to 2030 - Global Analysis By Type (Software Centric, Hardware Centric and Other Types), Medication and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，2023 年全球藥物醫囑遵從性市場規模為 44.031 億美元，預計到 2030 年將達到 136.153 億美元，複合年成長率為 17.5。

治療成功的一個重要部分是藥物醫囑遵從性，或患者遵守建議處方方案的程度。市面上有許多旨在改善和追蹤患者用藥醫囑遵從性的技術、治療方法和服務。該領域的創新包括穿戴式技術、智慧藥丸分配器、行動健康應用程式和患者教育計劃，以改善醫療保健提供者和患者之間的溝通，並最終確保患者遵守建議的用藥常規。

根據CMS.gov 2022年12月更新數據，2021年全國醫療保健支出將成長2.7%，達到4.3兆美元，即人均12,914美元，占美國國內生產總值（GDP）的18.3%。

監理舉措

全球醫療產業的政府和監管機構越來越認知到，不遵守藥物治療會對醫療保健結果和支出產生重大影響。為此，頒布了許多法律和指南來促進藥物醫囑遵從性計畫的使用。此外，鼓勵使用技術主導的藥物醫囑遵從性工具的指南、對使用藥物醫囑遵從性技術的醫療保健專業人員的付款獎勵以及將藥物醫囑遵從性測量涵蓋品質報告指標只是這些努力的幾個例子。支持性法律規範促進尖端醫囑遵從性服務和技術的創建和應用。

缺乏標準化

缺乏標準化協議和資料格式阻礙了技術連接，並使醫療保健組織難以實施整合方法。標準化的缺乏不僅使得建立全面且可互通的解決方案變得困難，而且還限制了醫囑遵從性干預的可擴展性和有效性。然而，醫療保健專業人員很難收集和評估各種醫囑遵從性技術的資料，從而更難得出有洞察力的推論並提供客製化的治療。

慢性病負擔增加

隨著糖尿病、心臟病和呼吸系統疾病等疾病變得越來越普遍，個人繼續按處方使用藥物以有效控制疾病至關重要。慢性病治療複雜且長期，因此確保患者遵守建議的用藥時間表對於避免問題和促進整體健康至關重要。此外，對醫囑遵從性解決方案不斷成長的需求正在推動支持和追蹤藥物依從性的產品和服務的創新。

藥物醫囑遵從性解決方案的成本

儘管尖端技術和數位平台提供了提高處方合規性的複雜方法，但與這些解決方案相關的初期成本和持續成本可能令人望而卻步。醫療保健付款人、醫療保健提供者以及在某些情況下的患者也會受到此成本問題的影響。在資源有限的環境中，實施和維護數位監控系統和智慧設備等醫囑遵從性技術可能會對醫療保健成本造成壓力。經濟限制可能會阻礙這些治療方法的廣泛採用，從而影響其有效性和對不同患者群體的可及性。

COVID-19 的影響

大流行的影響，包括醫療機構關閉和醫療系統超負荷，凸顯了患者按處方服用處方藥的重要性。作為管理和預防併發症的一種方法，藥物醫囑遵從性變得越來越重要。此外，大流行期間遠端醫療的普及為遠端監控和藥物醫囑遵從性支援創造了機會。

以軟體為中心的細分市場預計將在預測期內成為最大的細分市場

以軟體為中心的類別預計將佔據最大佔有率，重點是基於軟體的干涉措施，例如網路平台、行動應用程式和電子健康記錄連接。這些軟體解決方案通常包括給藥追蹤、即時監測和用藥提醒等功能。此外，它還促進患者和醫療保健專業人員之間的溝通，並實現客製化的醫囑遵從性計劃。透過整合人工智慧、機器學習和資料分析來根據特定患者需求客製化干涉措施，以軟體為中心的行業正在經歷快速創新。

預計癌症產業在預測期內將經歷最高的複合年成長率。

由於重點在於提高接受癌症治療的患者的藥物醫囑遵從性，腫瘤學領域預計將實現盈利成長。癌症藥物是如此複雜和強大，保持準確的依從性對於最大化治療效果至關重要。這些解決方案透過提供個體化藥物治療、劑量提醒和培訓資源來提高患者的理解和參與。以腫瘤學為重點的醫囑遵從性策略旨在透過確保患者遵循標靶治療、化療和免疫治療方案來減少給藥劑量的潛在影響。Masu。

佔有率最高的地區：

由於醫療基礎設施的進步、對慢性病的認知提高以及數位健康解決方案的使用增加，預計亞太地區將佔據最大佔有率。為了降低慢性病的發生率，越來越需要考慮人口規模和年齡的有效藥物醫囑遵從性措施。此外，亞太市場最近的開拓是擴大創建和使用以軟體為中心的解決方案，這些解決方案透過利用數位平台和行動應用程式來提高患者的參與度和醫囑遵從性。

複合年成長率最高的地區：

由於醫療保健投資和政府措施的增加，預計亞太地區將實現盈利成長。亞太地區多樣化的醫療保健形勢和獨特的經濟狀況證明了一種適應性強且具有文化敏感性的方法。因此，創新和客製化對於應對這個充滿活力且快速變化的區域藥物治療實施市場的獨特機會和挑戰至關重要。

免費客製化服務：

訂閱此報告的客戶可以利用以下免費自訂選項之一：

  • 公司簡介
    • 其他市場參與企業的綜合分析（最多 3 家公司）
    • 主要企業SWOT分析（最多3家企業）
  • 區域分割
    • 根據客戶興趣對主要國家的市場估計/預測/複合年成長率（註：基於可行性檢查）
  • 競爭基準化分析
    • 根據產品系列、地理分佈和策略聯盟對主要企業基準化分析

目錄

第1章執行摘要

第2章 前言

  • 概述
  • 相關利益者
  • 調查範圍
  • 調查方法
    • 資料探勘
    • 資料分析
    • 資料檢驗
    • 研究途徑
  • 研究資訊來源
    • 主要研究資訊來源
    • 二次研究資訊來源
    • 先決條件

第3章市場趨勢分析

  • 介紹
  • 促進因素
  • 抑制因素
  • 機會
  • 威脅
  • 新興市場
  • 新型冠狀病毒感染疾病（COVID-19）的影響

第4章波特五力分析

  • 供應商的議價能力
  • 買方議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭公司之間的敵對關係

第5章全球藥物醫囑遵從性市場：依類型

  • 介紹
  • 以軟體為中心
  • 以硬體為中心
    • 自動點膠系統
    • 電子托盤
    • 智慧藥瓶
  • 其他類型

第6章全球藥物醫囑遵從性市場：依藥物分類

  • 介紹
  • 肌肉骨骼系統
  • 胃
  • 癌症
  • 糖尿病
  • 中樞神經系統
  • 心血管
  • 風濕病
  • 其他藥品

第7章全球藥物醫囑遵從性市場：按地區

  • 介紹
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 歐洲其他地區
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 中東和非洲其他地區

第8章 主要進展

  • 合約、夥伴關係、協作和合資企業
  • 收購和合併
  • 新產品發布
  • 業務擴展
  • 其他關鍵策略

第9章 公司簡介

  • Aardex Group
  • AdhereTech Inc.,
  • Caredose
  • CareFusion（Becton Dickenson）
  • DrFirst.com, Inc.
  • ELucid MHealth
  • Fruitech Ltd.
  • Health Beacon
  • HealthEra
  • Johnson And Johnson Services Inc
  • McKesson Corporation
  • MedAdvisor International Pty Ltd
  • PHC Holdings Corporation
  • Propeller Health
  • Proteus Digital Health
Product Code: SMRC24449

According to Stratistics MRC, the Global Medication Adherence Market is accounted for $4,403.1 million in 2023 and is expected to reach $13,615.3 million by 2030 growing at a CAGR of 17.5% during the forecast period. An important component of medical treatment accomplishment is medication adherence, or the extent to which patients adhere to their recommended prescription regimes. A variety of technologies, therapies, and services are available on the market with the aim of enhancing and tracking patient adherence to drug regimes. In order to improve communication between healthcare providers and patients and eventually ensure individuals follow their recommended medication routines, innovations in this sector include wearable technology, smart pill dispensers, mobile health apps, and patient education programs.

According to a CMS.gov December 2022 update, national health expenditure grew 2.7% to USD 4.3 trillion in 2021, or USD 12,914 per person, and accounted for 18.3% of the Gross Domestic Product (GDP) in the United States.

Market Dynamics:

Driver:

Regulatory initiatives

The substantial impact that medication non-adherence has on healthcare outcomes and expenditures is becoming increasingly recognized by governments and regulatory authorities in the healthcare industry globally. In response, a number of laws and guidelines have been put into effect to promote the use of medication adherence programs. Additionally, guidelines encouraging the use of technology-driven adherence tools, payment incentives for healthcare professionals using adherence techniques, and the incorporation of adherence measurements into quality reporting metrics are just a few instances of these initiatives. A supportive regulatory framework promotes the creation and application of cutting-edge adherence services and technologies.

Restraint:

Lack of standardization

The lack of standardized protocols and data formats impedes technology connectivity, making it challenging for healthcare organizations to implement an integrated approach. This lack of standardization restricts the scalability and effectiveness of adherence interventions, in addition to making the creation of comprehensive and interoperable solutions more difficult. However, it may be challenging for healthcare professionals to gather and assess data from various adherence technologies, which makes it more difficult to arrive at insightful inferences and deliver customized therapy.

Opportunity:

Rising chronic disease burden

As diseases like diabetes, heart problems, and respiratory disorders become more common, it is crucial that individuals keep using medications as prescribed in order to effectively manage illness. Because chronic therapies are complex and long-term, it is essential for patients to adhere to their recommended drug schedules in order to avoid issues and enhance their overall health. Moreover, innovation in products and services that support and track medication compliance is being fueled by the increased need for adherence solutions.

Threat:

Cost of adherence solutions

The upfront costs and continuous expenses associated with these solutions can be prohibitively expensive, even though cutting-edge technologies and digital platforms provide sophisticated ways to enhance prescription compliance. Healthcare payers, providers, and, in certain situations, patients are all affected by this cost issue. In contexts with limited resources, the implementation and maintenance of adherence technologies like digital monitoring systems and smart devices could put pressure on healthcare costs. Financial constraints may prevent these treatments from being widely adopted, which would affect their efficacy and accessibility for a range of patient populations.

COVID-19 Impact:

The pandemic's effects, including lockdowns and overloaded healthcare systems, emphasized how important it is for patients to take their prescriptions as prescribed. Medication adherence has become more important as a way to manage and prevent complications, as there is a greater understanding of the way the virus can have serious effects on those with chronic diseases. Additionally, the pandemic's rapid telehealth uptake has created opportunities for remote monitoring and adherence assistance.

The software centric segment is expected to be the largest during the forecast period

With a focus on software-based interventions such as web platforms, mobile applications, and electronic health record connections, the software-centric category is predicted to have the largest share. Patients have the ability to manage their treatment programs with the help of these software solutions, which frequently include features like dosage tracking, real-time monitoring, and drug reminders. Additionally, they also make it easier for patients and healthcare professionals to communicate, enabling customized adherence plans. With the integration of AI, ML, and data analytics to customize interventions to specific patient needs, the software-centric sector is experiencing exponential innovation.

The oncology segment is expected to have the highest CAGR during the forecast period

With an emphasis on enhancing drug adherence for patients undergoing cancer treatment, the oncology segment is predicted to experience profitable growth. Because oncology medicines are so complex and intense, maintaining precise compliance is essential to maximizing therapeutic outcomes. These solutions improve the patient's understanding and participation by offering individualized drug treatments, dose reminders, and training resources. Adherence strategies with an emphasis on oncology are designed to mitigate the possible effects of missed doses, making sure patients execute their targeted therapy, chemotherapy, or immunotherapy regimes.

Region with largest share:

Owing to the region's developing healthcare infrastructure, growing awareness of chronic illnesses, and growing use of digital health solutions, the Asia-Pacific area is anticipated to hold the largest percentage. In order to address the incidence of chronic illnesses, there is an increasing need for medication adherence measures that are effective considering the size and age of the population. Moreover, a recent development in the Asia-Pacific market is the increased creation and use of software-centric solutions that improve patient engagement and adherence by utilizing digital platforms and mobile applications.

Region with highest CAGR:

As a result of growing healthcare investments and government initiatives, the Asia-Pacific area is anticipated to have profitable growth. The Asia Pacific region's varied healthcare landscape and distinct economic circumstances indicate adaptable and culturally sensitive approaches, which is why innovation and customization are essential for tackling the particular opportunities and challenges within the medication adoption market in this vibrant and rapidly changing region.

Key players in the market:

Some of the key players in Medication Adherence market include Aardex Group, AdhereTech Inc., Caredose, CareFusion (Becton Dickenson), DrFirst.com, Inc., ELucid MHealth, Fruitech Ltd., Health Beacon, HealthEra, Johnson And Johnson Services Inc, McKesson Corporation, MedAdvisor International Pty Ltd, PHC Holdings Corporation, Propeller Health and Proteus Digital Health.

Key Developments:

In August 2022, Athenahealth added an automated patient engagement feature to help with medication adherence. The new release of the athenaOne EHR and practice management suite includes DrFirst's RxInform automated patient messaging to help patients follow prescribed treatment plans.

In January 2022, CareDxl expanded its medication adherence services with the acquisition of the Transplant Pharmacy. The Transplant Pharmacy provides individualized transplant pharmacy services for patients at multiple transplant centers throughout the United States.

Types Covered:

  • Software Centric
  • Hardware Centric
  • Other Types

Medications Covered:

  • Musculoskeletal
  • Gastrointestinal
  • Oncology
  • Diabetes
  • Central Nervous System
  • Cardiovascular
  • Rheumatology
  • Other Medications

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Emerging Markets
  • 3.7 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Medication Adherence Market, By Type

  • 5.1 Introduction
  • 5.2 Software Centric
  • 5.3 Hardware Centric
    • 5.3.1 Automated Dispensing Systems
    • 5.3.2 Electronic Trays
    • 5.3.3 Smart Pill Bottles
  • 5.4 Other Types

6 Global Medication Adherence Market, By Medication

  • 6.1 Introduction
  • 6.2 Musculoskeletal
  • 6.3 Gastrointestinal
  • 6.4 Oncology
  • 6.5 Diabetes
  • 6.6 Central Nervous System
  • 6.7 Cardiovascular
  • 6.8 Rheumatology
  • 6.9 Other Medications

7 Global Medication Adherence Market, By Geography

  • 7.1 Introduction
  • 7.2 North America
    • 7.2.1 US
    • 7.2.2 Canada
    • 7.2.3 Mexico
  • 7.3 Europe
    • 7.3.1 Germany
    • 7.3.2 UK
    • 7.3.3 Italy
    • 7.3.4 France
    • 7.3.5 Spain
    • 7.3.6 Rest of Europe
  • 7.4 Asia Pacific
    • 7.4.1 Japan
    • 7.4.2 China
    • 7.4.3 India
    • 7.4.4 Australia
    • 7.4.5 New Zealand
    • 7.4.6 South Korea
    • 7.4.7 Rest of Asia Pacific
  • 7.5 South America
    • 7.5.1 Argentina
    • 7.5.2 Brazil
    • 7.5.3 Chile
    • 7.5.4 Rest of South America
  • 7.6 Middle East & Africa
    • 7.6.1 Saudi Arabia
    • 7.6.2 UAE
    • 7.6.3 Qatar
    • 7.6.4 South Africa
    • 7.6.5 Rest of Middle East & Africa

8 Key Developments

  • 8.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 8.2 Acquisitions & Mergers
  • 8.3 New Product Launch
  • 8.4 Expansions
  • 8.5 Other Key Strategies

9 Company Profiling

  • 9.1 Aardex Group
  • 9.2 AdhereTech Inc.,
  • 9.3 Caredose
  • 9.4 CareFusion (Becton Dickenson)
  • 9.5 DrFirst.com, Inc.
  • 9.6 ELucid MHealth
  • 9.7 Fruitech Ltd.
  • 9.8 Health Beacon
  • 9.9 HealthEra
  • 9.10 Johnson And Johnson Services Inc
  • 9.11 McKesson Corporation
  • 9.12 MedAdvisor International Pty Ltd
  • 9.13 PHC Holdings Corporation
  • 9.14 Propeller Health
  • 9.15 Proteus Digital Health

List of Tables

  • Table 1 Global Medication Adherence Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Medication Adherence Market Outlook, By Type (2021-2030) ($MN)
  • Table 3 Global Medication Adherence Market Outlook, By Software Centric (2021-2030) ($MN)
  • Table 4 Global Medication Adherence Market Outlook, By Hardware Centric (2021-2030) ($MN)
  • Table 5 Global Medication Adherence Market Outlook, By Automated Dispensing Systems (2021-2030) ($MN)
  • Table 6 Global Medication Adherence Market Outlook, By Electronic Trays (2021-2030) ($MN)
  • Table 7 Global Medication Adherence Market Outlook, By Smart Pill Bottles (2021-2030) ($MN)
  • Table 8 Global Medication Adherence Market Outlook, By Other Types (2021-2030) ($MN)
  • Table 9 Global Medication Adherence Market Outlook, By Medication (2021-2030) ($MN)
  • Table 10 Global Medication Adherence Market Outlook, By Musculoskeletal (2021-2030) ($MN)
  • Table 11 Global Medication Adherence Market Outlook, By Gastrointestinal (2021-2030) ($MN)
  • Table 12 Global Medication Adherence Market Outlook, By Oncology (2021-2030) ($MN)
  • Table 13 Global Medication Adherence Market Outlook, By Diabetes (2021-2030) ($MN)
  • Table 14 Global Medication Adherence Market Outlook, By Central Nervous System (2021-2030) ($MN)
  • Table 15 Global Medication Adherence Market Outlook, By Cardiovascular (2021-2030) ($MN)
  • Table 16 Global Medication Adherence Market Outlook, By Rheumatology (2021-2030) ($MN)
  • Table 17 Global Medication Adherence Market Outlook, By Other Medications (2021-2030) ($MN)
  • Table 18 North America Medication Adherence Market Outlook, By Country (2021-2030) ($MN)
  • Table 19 North America Medication Adherence Market Outlook, By Type (2021-2030) ($MN)
  • Table 20 North America Medication Adherence Market Outlook, By Software Centric (2021-2030) ($MN)
  • Table 21 North America Medication Adherence Market Outlook, By Hardware Centric (2021-2030) ($MN)
  • Table 22 North America Medication Adherence Market Outlook, By Automated Dispensing Systems (2021-2030) ($MN)
  • Table 23 North America Medication Adherence Market Outlook, By Electronic Trays (2021-2030) ($MN)
  • Table 24 North America Medication Adherence Market Outlook, By Smart Pill Bottles (2021-2030) ($MN)
  • Table 25 North America Medication Adherence Market Outlook, By Other Types (2021-2030) ($MN)
  • Table 26 North America Medication Adherence Market Outlook, By Medication (2021-2030) ($MN)
  • Table 27 North America Medication Adherence Market Outlook, By Musculoskeletal (2021-2030) ($MN)
  • Table 28 North America Medication Adherence Market Outlook, By Gastrointestinal (2021-2030) ($MN)
  • Table 29 North America Medication Adherence Market Outlook, By Oncology (2021-2030) ($MN)
  • Table 30 North America Medication Adherence Market Outlook, By Diabetes (2021-2030) ($MN)
  • Table 31 North America Medication Adherence Market Outlook, By Central Nervous System (2021-2030) ($MN)
  • Table 32 North America Medication Adherence Market Outlook, By Cardiovascular (2021-2030) ($MN)
  • Table 33 North America Medication Adherence Market Outlook, By Rheumatology (2021-2030) ($MN)
  • Table 34 North America Medication Adherence Market Outlook, By Other Medications (2021-2030) ($MN)
  • Table 35 Europe Medication Adherence Market Outlook, By Country (2021-2030) ($MN)
  • Table 36 Europe Medication Adherence Market Outlook, By Type (2021-2030) ($MN)
  • Table 37 Europe Medication Adherence Market Outlook, By Software Centric (2021-2030) ($MN)
  • Table 38 Europe Medication Adherence Market Outlook, By Hardware Centric (2021-2030) ($MN)
  • Table 39 Europe Medication Adherence Market Outlook, By Automated Dispensing Systems (2021-2030) ($MN)
  • Table 40 Europe Medication Adherence Market Outlook, By Electronic Trays (2021-2030) ($MN)
  • Table 41 Europe Medication Adherence Market Outlook, By Smart Pill Bottles (2021-2030) ($MN)
  • Table 42 Europe Medication Adherence Market Outlook, By Other Types (2021-2030) ($MN)
  • Table 43 Europe Medication Adherence Market Outlook, By Medication (2021-2030) ($MN)
  • Table 44 Europe Medication Adherence Market Outlook, By Musculoskeletal (2021-2030) ($MN)
  • Table 45 Europe Medication Adherence Market Outlook, By Gastrointestinal (2021-2030) ($MN)
  • Table 46 Europe Medication Adherence Market Outlook, By Oncology (2021-2030) ($MN)
  • Table 47 Europe Medication Adherence Market Outlook, By Diabetes (2021-2030) ($MN)
  • Table 48 Europe Medication Adherence Market Outlook, By Central Nervous System (2021-2030) ($MN)
  • Table 49 Europe Medication Adherence Market Outlook, By Cardiovascular (2021-2030) ($MN)
  • Table 50 Europe Medication Adherence Market Outlook, By Rheumatology (2021-2030) ($MN)
  • Table 51 Europe Medication Adherence Market Outlook, By Other Medications (2021-2030) ($MN)
  • Table 52 Asia Pacific Medication Adherence Market Outlook, By Country (2021-2030) ($MN)
  • Table 53 Asia Pacific Medication Adherence Market Outlook, By Type (2021-2030) ($MN)
  • Table 54 Asia Pacific Medication Adherence Market Outlook, By Software Centric (2021-2030) ($MN)
  • Table 55 Asia Pacific Medication Adherence Market Outlook, By Hardware Centric (2021-2030) ($MN)
  • Table 56 Asia Pacific Medication Adherence Market Outlook, By Automated Dispensing Systems (2021-2030) ($MN)
  • Table 57 Asia Pacific Medication Adherence Market Outlook, By Electronic Trays (2021-2030) ($MN)
  • Table 58 Asia Pacific Medication Adherence Market Outlook, By Smart Pill Bottles (2021-2030) ($MN)
  • Table 59 Asia Pacific Medication Adherence Market Outlook, By Other Types (2021-2030) ($MN)
  • Table 60 Asia Pacific Medication Adherence Market Outlook, By Medication (2021-2030) ($MN)
  • Table 61 Asia Pacific Medication Adherence Market Outlook, By Musculoskeletal (2021-2030) ($MN)
  • Table 62 Asia Pacific Medication Adherence Market Outlook, By Gastrointestinal (2021-2030) ($MN)
  • Table 63 Asia Pacific Medication Adherence Market Outlook, By Oncology (2021-2030) ($MN)
  • Table 64 Asia Pacific Medication Adherence Market Outlook, By Diabetes (2021-2030) ($MN)
  • Table 65 Asia Pacific Medication Adherence Market Outlook, By Central Nervous System (2021-2030) ($MN)
  • Table 66 Asia Pacific Medication Adherence Market Outlook, By Cardiovascular (2021-2030) ($MN)
  • Table 67 Asia Pacific Medication Adherence Market Outlook, By Rheumatology (2021-2030) ($MN)
  • Table 68 Asia Pacific Medication Adherence Market Outlook, By Other Medications (2021-2030) ($MN)
  • Table 69 South America Medication Adherence Market Outlook, By Country (2021-2030) ($MN)
  • Table 70 South America Medication Adherence Market Outlook, By Type (2021-2030) ($MN)
  • Table 71 South America Medication Adherence Market Outlook, By Software Centric (2021-2030) ($MN)
  • Table 72 South America Medication Adherence Market Outlook, By Hardware Centric (2021-2030) ($MN)
  • Table 73 South America Medication Adherence Market Outlook, By Automated Dispensing Systems (2021-2030) ($MN)
  • Table 74 South America Medication Adherence Market Outlook, By Electronic Trays (2021-2030) ($MN)
  • Table 75 South America Medication Adherence Market Outlook, By Smart Pill Bottles (2021-2030) ($MN)
  • Table 76 South America Medication Adherence Market Outlook, By Other Types (2021-2030) ($MN)
  • Table 77 South America Medication Adherence Market Outlook, By Medication (2021-2030) ($MN)
  • Table 78 South America Medication Adherence Market Outlook, By Musculoskeletal (2021-2030) ($MN)
  • Table 79 South America Medication Adherence Market Outlook, By Gastrointestinal (2021-2030) ($MN)
  • Table 80 South America Medication Adherence Market Outlook, By Oncology (2021-2030) ($MN)
  • Table 81 South America Medication Adherence Market Outlook, By Diabetes (2021-2030) ($MN)
  • Table 82 South America Medication Adherence Market Outlook, By Central Nervous System (2021-2030) ($MN)
  • Table 83 South America Medication Adherence Market Outlook, By Cardiovascular (2021-2030) ($MN)
  • Table 84 South America Medication Adherence Market Outlook, By Rheumatology (2021-2030) ($MN)
  • Table 85 South America Medication Adherence Market Outlook, By Other Medications (2021-2030) ($MN)
  • Table 86 Middle East & Africa Medication Adherence Market Outlook, By Country (2021-2030) ($MN)
  • Table 87 Middle East & Africa Medication Adherence Market Outlook, By Type (2021-2030) ($MN)
  • Table 88 Middle East & Africa Medication Adherence Market Outlook, By Software Centric (2021-2030) ($MN)
  • Table 89 Middle East & Africa Medication Adherence Market Outlook, By Hardware Centric (2021-2030) ($MN)
  • Table 90 Middle East & Africa Medication Adherence Market Outlook, By Automated Dispensing Systems (2021-2030) ($MN)
  • Table 91 Middle East & Africa Medication Adherence Market Outlook, By Electronic Trays (2021-2030) ($MN)
  • Table 92 Middle East & Africa Medication Adherence Market Outlook, By Smart Pill Bottles (2021-2030) ($MN)
  • Table 93 Middle East & Africa Medication Adherence Market Outlook, By Other Types (2021-2030) ($MN)
  • Table 94 Middle East & Africa Medication Adherence Market Outlook, By Medication (2021-2030) ($MN)
  • Table 95 Middle East & Africa Medication Adherence Market Outlook, By Musculoskeletal (2021-2030) ($MN)
  • Table 96 Middle East & Africa Medication Adherence Market Outlook, By Gastrointestinal (2021-2030) ($MN)
  • Table 97 Middle East & Africa Medication Adherence Market Outlook, By Oncology (2021-2030) ($MN)
  • Table 98 Middle East & Africa Medication Adherence Market Outlook, By Diabetes (2021-2030) ($MN)
  • Table 99 Middle East & Africa Medication Adherence Market Outlook, By Central Nervous System (2021-2030) ($MN)
  • Table 100 Middle East & Africa Medication Adherence Market Outlook, By Cardiovascular (2021-2030) ($MN)
  • Table 101 Middle East & Africa Medication Adherence Market Outlook, By Rheumatology (2021-2030) ($MN)
  • Table 102 Middle East & Africa Medication Adherence Market Outlook, By Other Medications (2021-2030) ($MN)